Beijing Tide Pharmaceutical Co., Ltd

This study is testing an experimental drug called TDI01 for people with moderate to severe chronic Graft-Versus-Host Disease (cGVHD) who have tried between 1 and 5 other treatments that didn't work well enough. The main goals are to see if TDI01 is effective at controlling the di…